Serina Therapeutics, Inc. ($SER)
Filing Information
| Accession Number | 0001301120-26-000014 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 17, 2026 |
| Document Date | Feb 3, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
69,000
Total Value
$0.00
P&L
+inf% (+$175,260.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Feb 3, 2026 | Grant/Award | 69,000 | $0.00 | $0.00 | 69,000 | Direct | โ | View Details |